Skip to main content

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 13

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 13

Concordance Between ctDNA Assay and FoundationOne

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Concordance Between ctDNA Assay and FoundationOne

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

Real World Data on Gi(l)Otrif® Dose Adjustment

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Real World Data on Gi(l)Otrif® Dose Adjustment

Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

Randomized Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Randomized Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • Page 158
  • Page 159
  • …
  • Next page Next
  • Last page Last
Subscribe to